The global Acrylate market report employs an extremely extensive and perceptive process that analyzes statistical data relating to services and products offered in the market. The research study is a pivotal document in understanding the needs and wants of the clients. The report is comprised of significant data about the leading companies and their marketing strategies. The Acrylate industry is witnessing an expansion and change of dynamics owing to the entry of several new players.

The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.

Key Companies Profiled in the Report are

Alpha Chemika

Arkema

BASF

Dow

Evonik

Formosa Plastics

Hexion

KH Chemical

KURARAY

LG Chem

Lucite

Mitsubishi

Acrylate Market, Till 2035: Distribution by Type of Product (2-Ethylhexyl Acrylate, Butyl Acrylate, Ethyl Acrylate, Methyl Acrylate), Type of Grade (Chemical Grade, Pharmaceutical Grade, Standard Grade, and, Technical Grade), Type of Application (Adhesive & Sealants, Fabrics, Paints & Coating, Papers & Paperboard, Personal Care Products, Plastics, Textiles, Others) Type of End User (Automotive, Construction, Consumer Goods, Electronics, Healthcare, Packaging, Textiles)

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.

Regional Analysis Covers:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Rest of the World (Australia, New Zealand and Other Countries)

To know more about the report, visit @

https://www.rootsanalysis.com/acrylate-market

Furthermore, the report provides analytical data in an organized format segmented into charts, tables, graphs, figures, and diagrams. This enables readers to understand the market scenario in an easy and beneficial manner. Moreover, the report aims to impart a prospective outlook and draw an informative conclusion to assist the reader in making lucrative business decisions. The report, in conclusion, provides a detailed analysis of the segments expected to dominate the market, the regional bifurcation, the estimated market size and share, and comprehensive SWOT analysis and Porters Five Forces Analysis.

Thank you for reading our report. For further queries, please connect with us, and our team will provide you the report best suited to your requirements.

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Roots Analysis

Gaurav Chaudhary

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/

By contrast, subcutaneous delivery enables patient self-medication and is less invasive, addressing many of the challenges associated with parenteral administration. Consequently, subcutaneous biologics and their associated formulation technologies have attracted considerable attention from stakeholders across the healthcare industry.

According to Roots Analysis the global subcutaneous biologics market size for approved drugs is projected to reach USD 275 billion by 2027 from USD 236 billion in the current year, growing at a CAGR of ~5%. Further, the global market size is projected to reach USD 2.7 billion by 2035 from USD 0.29 billion in the current year, growing at a CAGR of ~22%, in the forecast period.

Key Report Takeaways

Presently, more than 175 subcutaneous biologics have been approved for the treatment of various chronic disorders; around 50% of these biologics are proteins approved for once daily administration.

More than 340 subcutaneous biologics are in clinical-stages of development; around 10% of these biologics are antibodies that have received orphan drug designation.

Recent advances have prompted stakeholders to develop novel technology platforms to aid the development and administration of biologics through subcutaneous route.

In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel subcutaneous formulation technologies that can be utilized for the treatment of various indications.

The rising interest in this domain is reflected by the rise in partnership activity; in fact, close to 70% of the deals were inked in the last three years.

There are several new and innovative drug delivery systems that facilitate subcutaneous administration; we identified over 560 such systems that are presently available / under development.

With several self-medication enabling devices, such as wearable injectors and autoinjectors, available in the market, developers are actively differentiating their offerings by incorporating advanced, patient-friendly features.

Driven by the increased emphasis towards patient compliance and improved treatment outcome, the approved subcutaneous biologics market is likely to grow at a CAGR of ~5%, till 2027.

Owing to the numerous advantages offered by subcutaneous formulation technologies and increase in the number of licensing deals, the market is anticipated to grow at an annualized rate of 22.7% in the coming decade.

Market Players:

Top companies in subcutaneous biologics market are Adocia, Alteogen, Ascendis Pharma, CD Bioparticles, Creative Biolabs, Creative BioMart, Foresee Pharmaceuticals, Pacira Biosciences, Wyss Institute, Xeris Biopharma.

Regional Outlook

Based on the geographical regions, the approved subcutaneous biologics market can be segmented into five major regions, including North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. North America is anticipated to capture the majority share of the approved market in the current year and this trend is likely to remain unchanged during the forecast period. The advanced healthcare infrastructure and research capabilities in North America enable drug developers to conduct extensive clinical trials, which is necessary to meet the required regulatory guidelines provided by the approval bodies.

Market Segments

Based on the Type of Biologic, the market is segmented into Antibodies, Nucleotides and Proteins

The antibodies segment led the approved subcutaneous biologics market, capturing the largest revenue share (~60%) in the current year.

The nucleotides segment is anticipated to grow at an annualized growth rate of 13.1%, during the forecast period.

Based on the Type of Therapy, the market is segmented into Monotherapy, Combination Therapy, and Both Monotherapy and Combination Therapy

The segment for both monotherapy and combination therapy in the market is likely to capture the largest market share of around 50% in the current year.

The segment for both monotherapy and combination therapy is anticipated to grow at an annualized growth rate of 0.3%, during the forecast period.

Based on the Method of Administration, the market is segmented into Injection, Infusion, and Both Injection and Infusion

The injection segment led the approved subcutaneous biologics market, capturing the largest revenue share (~95%) in the current year.

The segment for both injection and infusion is anticipated to grow at an annualized growth rate of 4.7%, during the forecast period.

Based on the Therapeutic Area, the market is segmented into Autoimmune Disorders, Metabolic Disorders, Oncological Disorders, Hematological Disorders, Inflammatory Disorders, Neurological Disorders, Bone Disorders and Other Disorders

The autoimmune disorders segment led the approved subcutaneous biologics market, capturing the largest revenue share (~30%) in the current year.

The metabolic disorders segment is anticipated to grow at an annualized growth rate of 4.5%, during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America

North America dominated the approved market and accounted for the largest revenue share (~50%) in the current year.

In Asia-Pacific, the approved market is anticipated to show lucrative growth during the forecast period.

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Email: sales@rootsanalysis.com